Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-024724
Filing Date
2010-05-05
Accepted
2010-05-05 17:21:32
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v183201_10k.htm 10-K 844486
2 v183201_ex31-1.htm EX-31.1 16497
3 v183201_ex31-2.htm EX-31.2 16520
4 v183201_ex32-1.htm EX-32.1 5414
5 v183201_ex32-2.htm EX-32.2 5448
  Complete submission text file 0001144204-10-024724.txt   890087
Mailing Address 710 POST OAK SUITE 410 HOUSTON TX 77024
Business Address 710 POST OAK SUITE 410 HOUSTON TX 77024 713-780-0806
Oncolin Therapeutics, Inc. (Filer) CIK: 0001229089 (see all company filings)

EIN.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-50541 | Film No.: 10802977
SIC: 2834 Pharmaceutical Preparations